Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement

News   Nov 25, 2014

 
Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement
 
 
 

RELATED ARTICLES

Generating T Cells With a More Powerful Anti-cancer Effect

News

Studies of two T cell types that are equally activated by alpha-fetoprotein, a well-established antigen made by liver cancer, show that while one starts off with a bang, the other endures as the more powerful tumor fighter.

READ MORE

Gene Therapy Improves Heart Function by up to 25%

News

Intracoronary delivery of the gene vector was safe and improved heart function in a large animal model.

READ MORE

Cancer Cells’ Energy Source Blocked by Natural Compound

News

Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE